Treace Medical Concepts (TMCI) Profit After Tax Growth (1y) (2021 - 2026)
Treace Medical Concepts (TMCI) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.04% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 108.33% |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn | -13.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.42% |
| Dec 31, 2025 | -1,556.79% |
| Sep 30, 2025 | -7.56% |
| Jun 30, 2025 | 17.96% |
| Mar 31, 2025 | 14.75% |
| Dec 31, 2024 | 90.50% |
| Sep 30, 2024 | 13.57% |
| Jun 30, 2024 | -72.81% |
| Mar 31, 2024 | -38.81% |
| Dec 31, 2023 | -35.31% |
| Sep 30, 2023 | -44.41% |
| Jun 30, 2023 | 28.80% |
| Mar 31, 2023 | -48.89% |
| Dec 31, 2022 | 33.34% |
| Sep 30, 2022 | -89.05% |
| Jun 30, 2022 | -239.05% |
| Mar 31, 2022 | -271.55% |
| Dec 31, 2021 | -357.85% |
| Sep 30, 2021 | -141.73% |
| Jun 30, 2021 | -157.63% |